Hepatitis C Perspective

 
 
  • Vanquishing Hepatitis C: A Remarkable Success Story A look back at one of the singular achievements in medical research of the past 25 years, and what improvements are still to come.
  • AASLD 2020 Read clinically focused news coverage of key developments from AASLD 2020
  • ACG 2020 Read clinically focused news coverage of key developments from ACG 2020
  • Obeticholic Acid for NASH: Revolution or Just a Ripple? With FDA approval likely by year's end, Drs Jason Kramer and Nancy Reau consider what obeticholic acid may mean for this increasingly prevalent disease.
  • DDW 2020 Read clinically focused news coverage of key developments from DDW 2020
  • ILC 2020 Read clinically focused news coverage of key developments from ILC 2020
  • The Promise of Remdesivir for COVID-19 Treatment   WebMD Chief Medical Officer John Whyte talks with Dr Stuart Cohen about remdesivir for the possible treatment of COVID-19 infection, and when we might expect to see the development of a vaccine.
  • The Time to Eradicate Hepatitis C Is Now Dr William Balistreri says new guidelines recommending expansive screening may be daunting, but they are absolutely crucial if we want to progress further.
  • Opioid Use Disorder: Treatment Guide for Nonspecialists It may be impossible to rein in the epidemic of opioid use disorder in the United States unless primary care and other nonspecialists help manage it.
  • Hepatocellular Carcinoma: 5 Things to Know Get up to speed on the latest data surrounding the most common form of liver cancer.
  • GUILD 2020 Read clinically focused news coverage of key developments from GUILD 2020
  • Doctor Duo Counters Misperceptions on Addiction A married pair of physicians found that they had different perspectives on the opioid crisis -- so they wrote a book about it together.
  • Updated Guidance for Hepatitis C Virus Treatment in Primary Care Eradication of hepatitis C won't happen without the help of the primary care provider workforce.
  • AASLD 2019 Read clinically focused news coverage of key developments from AASLD 2019
  • INHSU 2019 Read clinically focused news coverage of key developments from INHSU 2019
  • 'Curing' Hepatitis C Is Not the End of Patient Care Antiviral therapy has given patients with hepatitis C infection a new lease on life, but the risk for cancer and reinfection means they still require continued monitoring.
  • Hepatitis C: 5 Things to Know Despite HCV being a curable disease with short-duration, well-tolerated finite therapy, it cannot be dismissed yet. Here are five issues that still need attention.
  • Hepatitis A: Breaking Out All Over Every encounter with those at risk is an opportunity to vaccinate against hepatitis A.
  • Discarded No More: HCV-Infected Organs Advance Transplantation Direct-acting antiviral therapy has made the use of HCV-infected organs a reality. Here is an inside look at one liver transplant program as they deliberate this option for their patients.
  • Patient Violence Against Physicians: What You Can Do When patients are sick or wounded, aggravation can lead to aggression. And the target is often a physician. Here's how to spot the warning signs and avoid an attack.